Click Therapeutics Announces Participation in Upcoming Technology and Biotechnology Investor Events


NEW YORK – August 03, 2023 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments today announced that company management will participate in the following investor events this month.

KeyBanc 24th Annual Technology Leadership Forum, August 6 - 8, 2023, Vail, CO: Randall Stanicky, Chief Financial Officer, and Han Chiu, Chief Technology Officer, will participate in one-on-one and small group meetings during the event.

BTIG Virtual Biotechnology Conference, August 7 - 8, 2023: Randall Stanicky will participate in a fireside chat and one-on-one meetings during the conference.

For additional information please reach out to the respective event organizations.

About Click Therapeutics
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click’s platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics.

For more information, visit and connect with us on LinkedIn.

Investor Contact

Daniel Busby

Media Contact

Jonni Mills